A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

NCT07369011 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

800

Enrollment

INDUSTRY

Sponsor class

Conditions

Sleep Apnea, Obstructive
Obesity
Overweight

Interventions

DRUG: Eloralintide
DRUG: Placebo

Sponsor

Eli Lilly and Company